These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24642392)

  • 1. A 2-year follow-up of oxidative stress levels in patients with ST-segment elevation myocardial infarction: a subanalysis of the ALPS-AMI study.
    Abe N; Kashima Y; Izawa A; Motoki H; Ebisawa S; Miyashita Y; Imamura H; Ikeda U
    Angiology; 2015 Mar; 66(3):271-7. PubMed ID: 24642392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
    Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A
    Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage.
    Bjerre M; Munk K; Sloth AD; Nielsen SS; Flyvbjerg A; Bøtker HE
    Scand Cardiovasc J; 2014 Aug; 48(4):209-15. PubMed ID: 24758546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.
    Roe MT; Li S; Thomas L; Wang TY; Alexander KP; Ohman EM; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):323-32. PubMed ID: 23652734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
    Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
    Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
    Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes.
    Cho HO; Nam CW; Lee HM; Shin HW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Hur SH; Kim YN; Kim KB
    Int J Cardiol; 2014 Jan; 170(3):376-80. PubMed ID: 24290071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Pedersen S; Mogelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Sørensen TB; Iversen A; Hvelplund A; Jensen JS
    Cardiology; 2012; 123(1):31-8. PubMed ID: 22964478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up.
    Mignano A; Pitruzzella V; Arnone G; Arnone MT; Rotolo A; Assennato P; Novo G; Corrado E; Novo S
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):27-32. PubMed ID: 23867910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
    Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
    Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.